| Structure | Chemical Name | CAS | MF |
|
1-(3,5-dimethylphenyl)propan-1-amine hydrochloride
|
2155855-34-6
|
C11H17N.ClH
|
|
1-(2-aminoethyl)cyclohexan-1-ol hydrochloride
|
2155856-37-2
|
C8H18ClNO
|
|
8-Chloro-6-trifluoromethyl-[1,2,4]triazolo[1,5-a]pyridine
|
2155874-86-3
|
C7H3ClF3N3
|
|
6-Bromo-8-chloro-[1,2,4]triazolo[1,5-a]pyridine
|
2155874-88-5
|
C6H3BrClN3
|
|
7-Methyl-6-nitro-[1,2,4]triazolo[1,5-a]pyridine
|
2155874-97-6
|
C7H6N4O2
|
|
5-(Trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine
|
2155874-98-7
|
C7H4F3N3
|
|
6,8-Dichloro-[1,2,4]triazolo[1,5-a]pyridine
|
2155875-35-5
|
C6H3Cl2N3
|
|
6-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine
|
2155875-42-4
|
C7H7ClN4
|
|
6-Chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
|
2155875-62-8
|
C7H6ClN3
|
|
6,8-Dibromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
|
2155875-72-0
|
C7H5Br2N3
|
|
6-Bromo-8-trifluoromethyl-[1,2,4]triazolo[1,5-a]pyridine
|
2155875-89-9
|
C7H3BrF3N3
|
|
6-Bromo-8-iodo-[1,2,4]triazolo[1,5-a]pyridine
|
2155875-91-3
|
C6H3BrIN3
|
|
8-Chloro-6-methyl-[1,2,4]triazolo[1,5-a]pyridine
|
2155876-04-1
|
C7H6ClN3
|
|
BIP
|
2156642-70-3
|
C31H29BF2N4O2
|
|
1,1'-Biphenyl, 2-bromo-3-(bromomethyl)-
|
2156651-21-5
|
C13H10Br2
|
|
Autotaxin-IN-3
|
2156655-68-2
|
C22H21N9O2
|
|
4,5,6,7-Tetrahydro-1H-pyrazolo[4,3-b]pyridine hydrochloride
|
2156657-30-4
|
C6H10ClN3
|
|
1,2-Dimethyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phthalate
|
2157414-14-5
|
C16H21BO6
|
|
Paclitaxel EP Impurity I
|
2157462-42-3
|
C61H62N2O16
|
|
Bezafibrate EP Impurity C
|
2157488-46-3
|
C20H22ClNO4
|
|
2-Phenazinamine, 5-(4-chlorophenyl)-3,5-dihydro-3-[(1-methylethyl)imino]-N-phenyl-
|
2158184-11-1
|
C27H23ClN4
|
|
HS1371
|
2158197-70-5
|
C24H24N4O
|
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxamide, 3-[6-(difluoromethyl)-7-(1-methyl-1H-pyrazol-4-yl)-4-isoquinolinyl]-1,4,6,7-tetrahydro-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-
|
2158265-96-2
|
C27H29F2N7O2
|
|
GNE-207
|
2158266-58-9
|
C29H30N6O3
|
|
1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carbonitrile
|
2158267-70-8
|
C11H16BN3O2
|
|
Isoquinoline, 4-bromo-6-(difluoromethyl)-7-(1-methyl-1H-pyrazol-4-yl)-
|
2158267-87-7
|
C14H10BrF2N3
|
|
KRAS G12C inhibitor 5
|
2158297-63-1
|
C32H37N7O2
|
|
4-Bromonaphthalen-2-yl pivalate
|
2158298-64-5
|
C15H15BrO2
|
|
2-Fluoro-3-methoxynaphthalen-1-ol
|
2158300-64-0
|
C11H9FO2
|
|
(S)-2-(piperazin-2-yl)acetonitrile dihydrochloride
|
2158301-19-8
|
C6H12ClN3
|
|
1-Benzyl 4-(tert-butyl) (S)-2-(cyanomethyl)piperazine-1,4-dicarboxylate
|
2158302-00-0
|
C19H25N3O4
|
|
Benzyl (S)-2-(cyanomethyl)piperazine-1-carboxylate
|
2158302-01-1
|
C14H17N3O2
|
|
(S)-benzyl 2-(cyanomethyl)piperazine-1-carboxylate hydrochloride
|
2158302-02-2
|
C14H18ClN3O2
|
|
tert-butyl (S)-4-(4-((benzyloxy)carbonyl)-3-(cyanomethyl)piperazin-1-yl)-2-chloro-5,8-dihydropyrido[3,4-d]pyrimidine-7(6H)-carboxylate
|
2158302-03-3
|
C26H31ClN6O4
|
|
benzyl (S)-2-(cyanomethyl)-4-(2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazine-1-carboxylate
|
2158302-05-5
|
C27H35N7O3
|
|
1-bromo-3-(methoxymethoxy)naphthalene
|
2158303-49-0
|
C12H11BrO2
|
|
PROTAC ER Degrader-3
|
2158322-29-1
|
C71H77N7O12
|
|
PAC
|
2158322-33-7
|
C94H107N13O16
|
|
5-TAMRA amine
|
2158336-48-0
|
C31H37ClN4O4
|
|
Indolo[2,3-b]carbazole, 5-[1,1'-biphenyl]-3-yl-5,7-dihydro
|
2159085-33-1
|
C30H20N2
|
|
tert-butyl ((1S,4R)-4-(4-methyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclopent-2-en-1-yl) carbonate/
|
2159120-36-0
|
C17H21N3O3
|
|
tert-butyl 6-(difluoromethyl)-5-fluoro-8-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate
|
2159123-11-0
|
C15H18F3NO3
|
|
Indolo[2,3-c]carbazole, 5-(4-[1,1'-biphenyl]-4-yl-2-quinazolinyl)-5,8-dihydro-8-phenyl-
|
2159132-86-0
|
C44H28N4
|
|
[S(R)]-N-[(R)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide
|
2160535-56-6
|
C39H40NO3PS
|
|
[S(R)]-N-[(S)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide
|
2160535-57-7
|
C39H40NO3PS
|
|
[S(R)]-N-[(R)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide
|
2160535-58-8
|
C42H46NO2PS
|
|
[S(R)]-N-[(S)-[4-(1,1-Dimethylethyl)phenyl][5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]methyl]-2-methyl-2-propanesulfinamide
|
2160535-59-9
|
C42H46NO2PS
|
|
3,3'-((2,2-diphenylethene-1,1-diyl)bis(4,1-phenylene))dipyridine
|
2160539-20-6
|
C36H26N2
|
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
C17H18Cl2N6
|
|
4-METHOXYPHENYL 3-O-ALLYL-2-O-BENZYL-4,6-O-BENZYLIDENE-BETA-D-GALACTOPYRANOSIDE
|
2160551-35-7
|
C30H32O7
|
|
5-bromo APINACA
|
2160555-51-9
|
C23H30BrN3O
|
|
5CAKB48
|
2160555-52-0
|
C23H30ClN3O
|
|
4-cyano CUMYL-BUT7AICA
|
2160555-53-1
|
C22H24N4O
|
|
CUMYL-PeGACLONE
|
2160555-55-3
|
C25H28N2O
|
|
3-(2,5-Dicarboxyphenyl)-1-ethyl-1H-imidazol-3-ium bromide
|
2160595-90-2
|
|
|
DJ001
|
2161305-12-8
|
C15H12N2O3
|
|
:4',5'-bis(4-carboxyphenyl)-3',6'-dimethyl-[1,1':2',1''-terphenyl]-4,4''-dicarboxylic acid
|
2161327-52-0
|
C36H26O8
|
|
5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-amine
|
2161380-87-4
|
C7H4BrClN2S2
|
|
Canagliflozin-10
|
2161394-94-9
|
C24H25FO5S
|
|
Suspenoidside B
|
2161432-08-0
|
C25H30O12
|
|
3-((4-Bromo-1H-pyrazol-1-yl)methyl)-5-chloropyridine
|
2161578-76-1
|
C9H7BrClN3
|
|
(3AR,6aR)-rel-1H-Furo[3,4-c]pyrrole-3a(6aH)-carboxylic acid
|
2162117-48-6
|
C18H25NO3
|
|
4-[(4-Aminobutyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
|
2162120-73-0
|
C17H21ClN4O4
|
|
Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-5-oxo-
|
2162120-77-4
|
C18H17N3O7
|
|
(S,R,S)-AHPC-amido-C5-acid
|
2162120-87-6
|
C29H40N4O6S
|
|
Rosuvastatin isomer-11
|
2162136-65-2
|
C26H36FN3O6S
|
|
S(R)]-N-[(S)-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]phenylmethyl]-2-methyl-2-propanesulfinamide
|
2162939-87-7
|
C38H38NO2PS
|
|
[S(R)]-N-[(1S)-1-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide
|
2162939-89-9
|
C36H42NO2PS
|
|
[S(R)]-N-[(S)-1-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]ethyl]-2-methyl-2-propanesulfinamide
|
2162939-90-2
|
C33H36NO2PS
|
|
[S(R)]-N-((1R)-(Adamantan-1-yl)(5-(diphenylphosphanyl)-9,9-dimethyl-9H-
xanthen-4-yl)methyl)-2-methyl-2-propanesulfinamide
|
2162939-91-3
|
C42H48NO2PS
|
|
[S(R)]-N-[(1R)-1-[5-(Diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl]-2,2-dimethylpropyl]-2-methyl-2-propanesulfinamide
|
2162939-92-4
|
C36H42NO2PS
|
|
BI-2545
|
2162961-71-7
|
C23H19F6N5O3
|
|
CU-CPT-9a
|
2162962-69-6
|
C16H13NO2
|
|
BAY-218
|
2162982-11-6
|
C20H17ClFN3O3
|
|
2,5-Bis(1,2,4-triazol-1-yl)terephthalic acid
|
2163052-04-6
|
C12H8N6O4
|
|
None
|
2163056-91-3
|
C22H20N4O
|
|
WY-135
|
2163060-83-9
|
C28H34ClN9O3S
|
|
4-(4-Pyridyl)Benzoic Acid
|
2163772-19-6
|
C42H45N7O8
|
|
PROTAC Mcl1 degrader-1
|
2163793-38-0
|
C45H45BrN6O8S
|
|
MCL-1/BCL-2-IN-2
|
2163793-44-8
|
C20H15BrN2O2S
|
|
MCL-1/BCL-2-IN-3
|
2163793-55-1
|
C27H25BrN2O5S
|
|
Sofosbuvir Impurity 19
|
2164516-85-0
|
C21H27FN3O9P
|
|
tert-butyl 1-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
2164962-36-9
|
C12H19NO3
|
|
AZ-1
|
2165322-94-9
|
C17H16BrF4NO2
|
|
PK150
|
2165324-62-7
|
C15H8ClF5N2O3
|
|
VU6010608
|
2165325-42-6
|
C18H15F3N4O4
|
|
(R)-3-(4-FLUOROPHENYL)PYRROLIDINE HYDROCHLORIDE
|
2165331-30-4
|
C10H13ClFN
|
|
4-(7-methoxyquinolin-4-yl)-2-methylphenol
|
2165340-32-7
|
C17H15NO2
|
|
{3-phenylbicyclo[1.1.1]pentan-1-yl}methanol
|
2165347-55-5
|
C12H14O
|
|
Benzaldehyde, 4,4'-[2,2-bis(4-methoxyphenyl)ethenylidene]bis-
|
2165348-28-5
|
C30H24O4
|
|
(5R)-4-[(2-Methylpropan-2-yl)oxycarbonyl]-1,4-oxazepane-5-carboxylic acid
|
2165380-89-0
|
C11H19NO5
|
|
Ethanol, 2-[[(3aR,4S,6R,6aR)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-
|
2165387-08-4
|
C10H19NO4
|
|
tert-butyl
(1R,5S,6R)-6-hydroxy-3-azabicyclo[3.1.0]hexane-3
-carboxylate
|
2165391-70-6
|
C10H17NO3
|
|
tert-butyl (2R,5S)-2-ethyl-5-methylpiperazine-1-carboxylate
|
2165403-17-6
|
C12H24N2O2
|
|
(2S,6S)-4-(tert-butoxycarbonyl)-6-methylmorpholine-2-carboxylic acid
|
2165414-92-4
|
C11H19NO5
|
|
tert-butyl ((1S,3S)-3-(hydroxymethyl)cyclohexyl)carbamate
|
2165427-41-6
|
C12H23NO3
|
|
1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, (αS,4S)-
|
2165431-90-1
|
C11H19NO3
|
|
(S)-1-(tert-butoxycarbonyl)-2,2-dimethylpiperidine-4-carboxylic acid
|
2165432-64-2
|
C13H23NO4
|
|
D-β-HoLys(Boc)-OH
|
2165435-43-6
|
C12H24N2O4
|
|
Cefuroxime Impurity 9
|
2165460-37-5
|
C8H10N2O4S
|